HomeNSRX • NYSEAMERICAN
add
Nasus Pharma Ltd
Previous close
$7.89
Year range
$5.90 - $9.99
Market cap
71.15M USD
Avg Volume
25.17K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 297.50K | 0.68% |
Net income | -330.50K | 21.03% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 284.00K | 47.15% |
Total assets | 717.00K | 61.49% |
Total liabilities | 3.93M | -7.36% |
Total equity | -3.21M | — |
Shares outstanding | 7.36M | — |
Price to book | -17.93 | — |
Return on assets | -103.73% | — |
Return on capital | 52.75% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -330.50K | 21.03% |
Cash from operations | -242.50K | 12.14% |
Cash from investing | — | — |
Cash from financing | -55.50K | — |
Net change in cash | -302.50K | -11.83% |
Free cash flow | -186.88K | -0.40% |
About
Founded
2019
Website
Employees
2
